Position in ZTS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$167,452,266
-$42,693,933 QoQ
Shares Held
1,416,566
-15.2% QoQ
Ownership
0.338%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.62011371160962.ToString("F0")%
Shared 0.ToString("F0")%
None 1.379886288390375.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BROWN BROTHERS HARRIMAN & CO holds $168,196,691 across 13 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (99.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
1,416,566 | $167,452,266 | |
| 2 | VTRS |
Viatris Inc
|
29,552 | $399,247 | |
| 3 | HLN |
Haleon plc
|
15,232 | $152,472 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
6,812 | $126,158 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
40 | $23,719 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
1,000 | $13,850 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
187 | $9,666 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
243 | $8,036 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $167,452,266 | 1,416,566 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $210,146,199 | 1,670,213 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $274,368,436 | 1,875,126 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $299,191,790 | 1,918,511 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $317,244,162 | 1,926,779 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $317,177,134 | 1,946,708 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $393,387,274 | 2,013,447 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $354,064,743 | 2,042,367 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $350,181,956 | 2,069,511 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $414,959,372 | 2,102,444 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $370,649,601 | 2,130,415 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $373,339,569 | 2,167,932 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $370,578,160 | 2,226,497 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $331,182,922 | 2,259,863 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $343,594,158 | 2,317,042 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $397,715,472 | 2,313,779 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $436,591,319 | 2,315,029 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $710,777,395 | 2,912,664 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $573,866,579 | 2,955,942 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $567,091,057 | 3,042,987 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $493,192,399 | 3,131,778 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $577,119,684 | 3,487,128 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $599,671,639 | 3,626,242 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $527,771,599 | 3,851,223 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $469,215,789 | 3,986,879 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||